4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-043541
Chief Financial Officer sold 734 shares at $21.26 ($15,605)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-07-28 | Sale | −734 | $21.26 | $15,605 | 52,218 | D |
| Open-market sales · 734 sh · avg $21.26 · $15,605 | |||||||
Loading xslF345X03/doc4.xml…